マルチモーダルイメージング市場：技術別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023年～2032年

マルチモーダルイメージング市場は、2022年に44億米ドルと評価され、2023年から2032年にかけてCAGR 6.1%で成長し、2032年には79億米ドルに達すると予測されています。

マルチモーダルイメージング市場は、医療機器・用品分野からのマルチモーダルイメージングシステム需要の増加により、2023年から2032年にかけて6.1%の大幅な成長率を記録する可能性が高いです。

以下のような慢性疾患の流行が増加しています。

がんや心血管疾患などの慢性疾患の増加は、早期発見、正確な診断、疾患進行のモニタリングのための高度なイメージングソリューションを必要とし、これがマルチモーダルイメージング市場の成長に寄与しています。例えば、米国がん協会は、2023年に米国で新たに約1,958,310人のがん患者が診断されると推定しています。さらに、イメージング技術の進歩がマルチモーダルイメージングの成長に寄与しています。個々のモダリティが解像度、速度、感度の点で向上するにつれて、これらの技術を組み合わせることがさらに強力になり、包括的な画像診断のための機能が強化されます。逆に、マルチモーダルイメージング装置は高価であるため、導入が制限され、市場成長に悪影響を及ぼします。一方、新興市場における成長機会や画像処理システムの技術的進歩の高まりは、市場成長の好機となります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

• 市場の定義と範囲
• 主な調査結果
  • 影響要因
  • 主な投資機会
• ポーターのファイブフォース分析
• 市場力学
  • 促進要因
    • 慢性疾患の増加
    • 画像診断モダリティの進歩
    • マルチモーダルイメージングシステムの応用拡大
  • 抑制要因
    • マルチモーダルイメージングシステムの高コスト
  • 機会
    • 新興市場における成長機会

第4章 マルチモーダルイメージング市場：技術別

• 概要
• PET/CTシステム
• PET/MRシステム
• SPECT/CTシステム
• その他

第5章 マルチモーダルイメージング市場：用途別

• 概要
• 脳・神経
• 循環器
• 腫瘍学
• 眼科
• その他

第6章 マルチモーダルイメージング市場：エンドユーザー別

• 概要
• 病院
• 画像診断センター
• その他

第7章 マルチモーダルイメージング市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • その他
• ラテンアメリカ・中東・アフリカ
  • ブラジル
  • サウジアラビア
  • 南アフリカ
  • その他

第8章 競争情勢

• イントロダクション
• 主要成功戦略
• 主要10社の製品マッピング
• 競合ダッシュボード
• 競合ヒートマップ
• 主要企業のポジショニング、2022年

第9章 企業プロファイル

• GE Healthcare
• Canon Inc.
• Topcon Corporation
• Bruker Corporation
• Spectrum Dynamics Medical, LLC
• Mediso Ltd.
• MR Solutions
• Neusoft Corporation
• Koninklijke Philips N.V.
• Siemens

LIST OF TABLES

• TABLE 01. GLOBAL MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 02. MULTIMODAL IMAGING MARKET FOR PET/CT SYSTEMS, BY REGION, 2022-2032 ($MILLION)
• TABLE 03. MULTIMODAL IMAGING MARKET FOR PET/MR SYSTEMS, BY REGION, 2022-2032 ($MILLION)
• TABLE 04. MULTIMODAL IMAGING MARKET FOR SPECT/CT SYSTEMS, BY REGION, 2022-2032 ($MILLION)
• TABLE 05. MULTIMODAL IMAGING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 06. GLOBAL MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 07. MULTIMODAL IMAGING MARKET FOR BRAIN AND NEUROLOGY, BY REGION, 2022-2032 ($MILLION)
• TABLE 08. MULTIMODAL IMAGING MARKET FOR CARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
• TABLE 09. MULTIMODAL IMAGING MARKET FOR ONCOLOGY, BY REGION, 2022-2032 ($MILLION)
• TABLE 10. MULTIMODAL IMAGING MARKET FOR OPHTHALMOLOGY, BY REGION, 2022-2032 ($MILLION)
• TABLE 11. MULTIMODAL IMAGING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 12. GLOBAL MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 13. MULTIMODAL IMAGING MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
• TABLE 14. MULTIMODAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 15. MULTIMODAL IMAGING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 16. MULTIMODAL IMAGING MARKET, BY REGION, 2022-2032 ($MILLION)
• TABLE 17. NORTH AMERICA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 18. NORTH AMERICA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 19. NORTH AMERICA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 20. NORTH AMERICA MULTIMODAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 21. U.S. MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 22. U.S. MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 23. U.S. MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 24. CANADA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 25. CANADA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 26. CANADA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 27. MEXICO MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 28. MEXICO MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 29. MEXICO MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 30. EUROPE MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 31. EUROPE MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 32. EUROPE MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 33. EUROPE MULTIMODAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 34. GERMANY MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 35. GERMANY MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 36. GERMANY MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 37. FRANCE MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 38. FRANCE MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 39. FRANCE MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 40. UK MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 41. UK MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 42. UK MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 43. ITALY MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 44. ITALY MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 45. ITALY MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 46. SPAIN MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 47. SPAIN MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 48. SPAIN MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 49. REST OF EUROPE MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 50. REST OF EUROPE MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 51. REST OF EUROPE MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 52. ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 53. ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 54. ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 55. ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 56. JAPAN MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 57. JAPAN MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 58. JAPAN MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 59. CHINA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 60. CHINA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 61. CHINA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 62. INDIA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 63. INDIA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 64. INDIA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 65. AUSTRALIA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 66. AUSTRALIA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 67. AUSTRALIA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 68. SOUTH KOREA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 69. SOUTH KOREA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 70. SOUTH KOREA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 71. REST OF ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 72. REST OF ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 73. REST OF ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 74. LAMEA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 75. LAMEA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 76. LAMEA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 77. LAMEA MULTIMODAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 78. BRAZIL MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 79. BRAZIL MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 80. BRAZIL MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 81. SAUDI ARABIA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 82. SAUDI ARABIA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 83. SAUDI ARABIA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 84. SOUTH AFRICA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 85. SOUTH AFRICA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 86. SOUTH AFRICA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 87. REST OF LAMEA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
• TABLE 88. REST OF LAMEA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
• TABLE 89. REST OF LAMEA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 90. GE HEALTHCARE: KEY EXECUTIVES
• TABLE 91. GE HEALTHCARE: COMPANY SNAPSHOT
• TABLE 92. GE HEALTHCARE: PRODUCT SEGMENTS
• TABLE 93. GE HEALTHCARE: SERVICE SEGMENTS
• TABLE 94. GE HEALTHCARE: PRODUCT PORTFOLIO
• TABLE 95. CANON INC.: KEY EXECUTIVES
• TABLE 96. CANON INC.: COMPANY SNAPSHOT
• TABLE 97. CANON INC.: PRODUCT SEGMENTS
• TABLE 98. CANON INC.: PRODUCT PORTFOLIO
• TABLE 99. TOPCON CORPORATION: KEY EXECUTIVES
• TABLE 100. TOPCON CORPORATION: COMPANY SNAPSHOT
• TABLE 101. TOPCON CORPORATION: PRODUCT SEGMENTS
• TABLE 102. TOPCON CORPORATION: PRODUCT PORTFOLIO
• TABLE 103. TOPCON CORPORATION: KEY STRATERGIES
• TABLE 104. BRUKER CORPORATION: KEY EXECUTIVES
• TABLE 105. BRUKER CORPORATION: COMPANY SNAPSHOT
• TABLE 106. BRUKER CORPORATION: PRODUCT SEGMENTS
• TABLE 107. BRUKER CORPORATION: PRODUCT PORTFOLIO
• TABLE 108. SPECTRUM DYNAMICS MEDICAL, LLC: KEY EXECUTIVES
• TABLE 109. SPECTRUM DYNAMICS MEDICAL, LLC: COMPANY SNAPSHOT
• TABLE 110. SPECTRUM DYNAMICS MEDICAL, LLC: PRODUCT SEGMENTS
• TABLE 111. SPECTRUM DYNAMICS MEDICAL, LLC: PRODUCT PORTFOLIO
• TABLE 112. SPECTRUM DYNAMICS MEDICAL, LLC: KEY STRATERGIES
• TABLE 113. MEDISO LTD.: KEY EXECUTIVES
• TABLE 114. MEDISO LTD.: COMPANY SNAPSHOT
• TABLE 115. MEDISO LTD.: PRODUCT SEGMENTS
• TABLE 116. MEDISO LTD.: PRODUCT PORTFOLIO
• TABLE 117. MEDISO LTD.: KEY STRATERGIES
• TABLE 118. MR SOLUTIONS: KEY EXECUTIVES
• TABLE 119. MR SOLUTIONS: COMPANY SNAPSHOT
• TABLE 120. MR SOLUTIONS: PRODUCT SEGMENTS
• TABLE 121. MR SOLUTIONS: PRODUCT PORTFOLIO
• TABLE 122. NEUSOFT CORPORATION: KEY EXECUTIVES
• TABLE 123. NEUSOFT CORPORATION: COMPANY SNAPSHOT
• TABLE 124. NEUSOFT CORPORATION: PRODUCT SEGMENTS
• TABLE 125. NEUSOFT CORPORATION: PRODUCT PORTFOLIO
• TABLE 126. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
• TABLE 127. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
• TABLE 128. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS
• TABLE 129. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
• TABLE 130. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
• TABLE 131. SIEMENS: KEY EXECUTIVES
• TABLE 132. SIEMENS: COMPANY SNAPSHOT
• TABLE 133. SIEMENS: PRODUCT SEGMENTS
• TABLE 134. SIEMENS: PRODUCT PORTFOLIO
• TABLE 135. SIEMENS: KEY STRATERGIES

LIST OF FIGURES

• FIGURE 01. MULTIMODAL IMAGING MARKET, 2022-2032
• FIGURE 02. SEGMENTATION OF MULTIMODAL IMAGING MARKET,2022-2032
• FIGURE 03. TOP IMPACTING FACTORS IN MULTIMODAL IMAGING MARKET (2022 TO 2032)
• FIGURE 04. TOP INVESTMENT POCKETS IN MULTIMODAL IMAGING MARKET (2023-2032)
• FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
• FIGURE 06. LOW THREAT OF NEW ENTRANTS
• FIGURE 07. LOW THREAT OF SUBSTITUTES
• FIGURE 08. LOW INTENSITY OF RIVALRY
• FIGURE 09. LOW BARGAINING POWER OF BUYERS
• FIGURE 10. GLOBAL MULTIMODAL IMAGING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
• FIGURE 11. MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
• FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR PET/CT SYSTEMS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 13. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR PET/MR SYSTEMS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR SPECT/CT SYSTEMS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 16. MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022 AND 2032(%)
• FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR BRAIN AND NEUROLOGY, BY COUNTRY 2022 AND 2032(%)
• FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY 2022 AND 2032(%)
• FIGURE 19. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY 2022 AND 2032(%)
• FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR OPHTHALMOLOGY, BY COUNTRY 2022 AND 2032(%)
• FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 22. MULTIMODAL IMAGING MARKET, BY END USER, 2022 AND 2032(%)
• FIGURE 23. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 24. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 25. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 26. MULTIMODAL IMAGING MARKET BY REGION, 2022 AND 2032(%)
• FIGURE 27. U.S. MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 28. CANADA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 29. MEXICO MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 30. GERMANY MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 31. FRANCE MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 32. UK MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 33. ITALY MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 34. SPAIN MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 35. REST OF EUROPE MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 36. JAPAN MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 37. CHINA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 38. INDIA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 39. AUSTRALIA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 40. SOUTH KOREA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 41. REST OF ASIA-PACIFIC MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 42. BRAZIL MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 43. SAUDI ARABIA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 44. SOUTH AFRICA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 45. REST OF LAMEA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
• FIGURE 46. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
• FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
• FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
• FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
• FIGURE 50. COMPETITIVE DASHBOARD
• FIGURE 51. COMPETITIVE HEATMAP: MULTIMODAL IMAGING MARKET
• FIGURE 52. TOP PLAYER POSITIONING, 2022
• FIGURE 53. GE HEALTHCARE: NET REVENUE, 2021-2022 ($MILLION)
• FIGURE 54. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 55. GE HEALTHCARE: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 56. CANON INC.: NET SALES, 2020-2022 ($MILLION)
• FIGURE 57. CANON INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 58. CANON INC.: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 59. TOPCON CORPORATION: NET SALES, 2021-2023 ($MILLION)
• FIGURE 60. TOPCON CORPORATION: REVENUE SHARE BY SEGMENT, 2023 (%)
• FIGURE 61. TOPCON CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
• FIGURE 62. BRUKER CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 63. BRUKER CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
• FIGURE 64. BRUKER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 65. BRUKER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 66. NEUSOFT CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 67. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
• FIGURE 68. KONINKLIJKE PHILIPS N.V.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
• FIGURE 69. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 70. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 71. SIEMENS: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 72. SIEMENS: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
• FIGURE 73. SIEMENS: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 74. SIEMENS: REVENUE SHARE BY REGION, 2022 (%)

According to a new report published by Allied Market Research, titled, "Multimodal Imaging Market," The multimodal imaging market was valued at $4.4 billion in 2022, and is estimated to reach $7.9 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032. The Multimodal Imaging Market is likely to experience a significant growth rate of 6.1% from 2023-2032 owing to increase in demand for multimodal imaging systems from medical device and supplies sector - Allied Market Research

The rise in prevalence of chronic diseases, such as cancer and cardiovascular disorders, necessitates advanced imaging solutions for early detection, accurate diagnosis, and monitoring of disease progression which contributes toward the multimodal imaging market growth. For instance, in 2023, American Cancer Society estimated that around 1,958,310 new cancer cases is expected to be diagnosed in U.S. In addition, ongoing advancements in imaging technologies contribute to the growth of multimodal imaging. As individual modalities improve in terms of resolution, speed, and sensitivity, the combination of these technologies becomes even more powerful, offering enhanced capabilities for comprehensive imaging. Conversely, the high cost of the multimodal imaging devices limit the adoption and negatively impact the market growth. On the other hand, growth opportunities in emerging markets and rise in technological advancements in imaging systems provide lucrative opportunities for market growth.

The multimodal imaging market is segmented into technology, application, end user, and region. By technology, the market is segregated into PET/CT systems, PET/MR systems, SPECT/CT systems, and others. By application, the market is categorized into brain & neurology, cardiology, oncology, ophthalmology, and others. By end user, the market is classified into hospitals, diagnostic imaging centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Major key players that operate in the multimodal imaging market are GE Healthcare, Koninklijke Philips N.V., Canon Inc., Siemens, Topcon Corporation, Bruker Corporation, Spectrum Dynamics Medical, Mediso Ltd., MR Solutions, and Neusoft Corporation. Key players have adopted expansion, acquisition, product approval, partnership, and agreement as key developmental strategies to improve the product portfolio of the multimodal imaging market. For instance, in July 2021, Topcon Corporation announced that it has acquired VISIA Imaging S.r.l, an ophthalmic device manufacturer headquartered in suburban Florence, Italy.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the multimodal imaging market analysis from 2022 to 2032 to identify the prevailing multimodal imaging market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the multimodal imaging market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global multimodal imaging market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Technology

• PET/CT Systems
• PET/MR Systems
• SPECT/CT Systems
• Others

By Application

• Brain and Neurology
• Cardiology
• Oncology
• Ophthalmology
• Others

By End User

• Hospitals
• Diagnostic Imaging Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• GE Healthcare
• Mediso Ltd.
• MR Solutions
• Topcon Corporation
• Siemens
• Koninklijke Philips N.V.
• Bruker Corporation
• Canon Inc.
• Neusoft Corporation
• Spectrum Dynamics Medical, LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Rise in prevalence of chronic diseases
    • 3.4.1.2. Advancements in diagnostic imaging modalities
    • 3.4.1.3. Growing application of multimodal imaging systems
  • 3.4.2. Restraints
    • 3.4.2.1. High cost of multimodal imaging systems
  • 3.4.3. Opportunities
    • 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. PET/CT Systems
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. PET/MR Systems
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. SPECT/CT Systems
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country
• 4.5. Others
  • 4.5.1. Key market trends, growth factors and opportunities
  • 4.5.2. Market size and forecast, by region
  • 4.5.3. Market share analysis by country

CHAPTER 5: MULTIMODAL IMAGING MARKET, BY APPLICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Brain and Neurology
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Cardiology
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Oncology
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Ophthalmology
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country
• 5.6. Others
  • 5.6.1. Key market trends, growth factors and opportunities
  • 5.6.2. Market size and forecast, by region
  • 5.6.3. Market share analysis by country

CHAPTER 6: MULTIMODAL IMAGING MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Diagnostic Imaging Centers
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Others
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: MULTIMODAL IMAGING MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Technology
  • 7.2.3. Market size and forecast, by Application
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Technology
    • 7.2.5.1.2. Market size and forecast, by Application
    • 7.2.5.1.3. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Technology
    • 7.2.5.2.2. Market size and forecast, by Application
    • 7.2.5.2.3. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Technology
    • 7.2.5.3.2. Market size and forecast, by Application
    • 7.2.5.3.3. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Technology
  • 7.3.3. Market size and forecast, by Application
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Technology
    • 7.3.5.1.2. Market size and forecast, by Application
    • 7.3.5.1.3. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Technology
    • 7.3.5.2.2. Market size and forecast, by Application
    • 7.3.5.2.3. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Technology
    • 7.3.5.3.2. Market size and forecast, by Application
    • 7.3.5.3.3. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Technology
    • 7.3.5.4.2. Market size and forecast, by Application
    • 7.3.5.4.3. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Technology
    • 7.3.5.5.2. Market size and forecast, by Application
    • 7.3.5.5.3. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Technology
    • 7.3.5.6.2. Market size and forecast, by Application
    • 7.3.5.6.3. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Technology
  • 7.4.3. Market size and forecast, by Application
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Technology
    • 7.4.5.1.2. Market size and forecast, by Application
    • 7.4.5.1.3. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Technology
    • 7.4.5.2.2. Market size and forecast, by Application
    • 7.4.5.2.3. Market size and forecast, by End User
    • 7.4.5.3. India
    • 7.4.5.3.1. Market size and forecast, by Technology
    • 7.4.5.3.2. Market size and forecast, by Application
    • 7.4.5.3.3. Market size and forecast, by End User
    • 7.4.5.4. Australia
    • 7.4.5.4.1. Market size and forecast, by Technology
    • 7.4.5.4.2. Market size and forecast, by Application
    • 7.4.5.4.3. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Technology
    • 7.4.5.5.2. Market size and forecast, by Application
    • 7.4.5.5.3. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Technology
    • 7.4.5.6.2. Market size and forecast, by Application
    • 7.4.5.6.3. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Technology
  • 7.5.3. Market size and forecast, by Application
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Technology
    • 7.5.5.1.2. Market size and forecast, by Application
    • 7.5.5.1.3. Market size and forecast, by End User
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Market size and forecast, by Technology
    • 7.5.5.2.2. Market size and forecast, by Application
    • 7.5.5.2.3. Market size and forecast, by End User
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Market size and forecast, by Technology
    • 7.5.5.3.2. Market size and forecast, by Application
    • 7.5.5.3.3. Market size and forecast, by End User
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Market size and forecast, by Technology
    • 7.5.5.4.2. Market size and forecast, by Application
    • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product mapping of top 10 player
• 8.4. Competitive dashboard
• 8.5. Competitive heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. GE Healthcare
  • 9.1.1. Company overview
  • 9.1.2. Key executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
• 9.2. Canon Inc.
  • 9.2.1. Company overview
  • 9.2.2. Key executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
• 9.3. Topcon Corporation
  • 9.3.1. Company overview
  • 9.3.2. Key executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
  • 9.3.7. Key strategic moves and developments
• 9.4. Bruker Corporation
  • 9.4.1. Company overview
  • 9.4.2. Key executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
• 9.5. Spectrum Dynamics Medical, LLC
  • 9.5.1. Company overview
  • 9.5.2. Key executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Key strategic moves and developments
• 9.6. Mediso Ltd.
  • 9.6.1. Company overview
  • 9.6.2. Key executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
  • 9.6.6. Key strategic moves and developments
• 9.7. MR Solutions
  • 9.7.1. Company overview
  • 9.7.2. Key executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
• 9.8. Neusoft Corporation
  • 9.8.1. Company overview
  • 9.8.2. Key executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Business performance
• 9.9. Koninklijke Philips N.V.
  • 9.9.1. Company overview
  • 9.9.2. Key executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
  • 9.9.7. Key strategic moves and developments
• 9.10. Siemens
  • 9.10.1. Company overview
  • 9.10.2. Key executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance
  • 9.10.7. Key strategic moves and developments